3 active not recruiting, 1 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 3, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Metastatic Malignant Neoplasm in the Bone: new trials by email Literature Review of Metastatic Malignant Neoplasm in the Bone trials Research Report on Metastatic Malignant Neoplasm in the Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial Best Practice, Biospecimen Collection, Bone Metastases Treatment - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm | Phase 3 | Active not recruiting | NRG Oncology | 280 | 2025-05-07 | 2026-08-17 |
| Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Biospecimen Collection, Bone Scan, Cabozantinib - Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 1175 | 2019-06-07 | 2026-10-26 |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival Stereotactic Body Radiotherapy, Surgery - Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 129 | 2014-12-24 | 2026-07-10 |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride - Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 312 | 2014-12-12 | 2026-10-22 |
Lymphatic Metastasis (2) · Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Neoplasm Metastasis (1) · Sarcoma, Ewing (1)
Neoplasms (4) · Neoplastic Processes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Neoplasm Metastasis (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Adenocarcinoma (1) · Breast Diseases (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Male Urogenital Diseases (1)
Radiosurgery (3) · Magnetic Resonance Spectroscopy (2) · Radiation (2) · Specimen Handling (2) · CTLA-4 Antigen (1) · Congresses as Topic (1) · Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Ifosfamide (1) · Ipilimumab (1) · Nivolumab (1) · Observation (1) · Practice Guidelines as Topic (1) · Standard of Care (1)
NRG Oncology (2) · National Cancer Institute (NCI) (2)
United States (4) · Canada (3) · Puerto Rico (2) · Saudi Arabia (1) · South Korea (1)
Erin F Gillespie (1) · Steven G DuBois (1) · Steven J Chmura (1) · Tian Zhang (1)
PMID 35304832, PMID 35383907, PMID 35602670, PMID 36669140, PMID 41825136, PMID 42208702
U10CA098543 (1), U10CA180821 (1), U10CA180868 (1), U10CA180886 (1), UG1CA189867 (1)